VCYT

25.4001.44%
RS

Robert S. Epstein

Independent Director

Dr. Robert S. Epstein, also known as Rob, M.D., M.S., is an Independent Director of Mammogen, Inc. since October 2026. He is Senior Advisor of TriAxia Health, Inc. Dr. Epstein is Director of PinkDx, Inc. from August 2024. He served as Independent Chairperson of the Board of Directors at Veracyte Sd, Inc. (formerly known as Decipher Biosciences, Inc.). since November 2019 until March 2021. He serves as Member of Strategic Advisory Board at Medocity, Inc. He serves as Director at Tasso, Inc. Dr. Epstein is the Chief Executive Officer of Epstein Health Limited Liability Company and has provided strategic consultancy services to life sciences companies since June 2013. He has been an Independent Director of Fate Therapeutics, Inc. since March 17, 2014. He has been an Independent Director of Veracyte, Inc. since January 12, 2015 and serves as its Independent Chair since June 08, 2023. Dr. Epstein served as the President of United BioSource Corporation at Medco Health Solutions, Inc. since September 2011 to 2012. Dr. Epstein is a strategic consultant to life sciences companies since 2013 and an epidemiologist with extensive expertise in pharmacoeconomics and health outcomes research, having held various positions in academia and public health. He served as the President of Advanced Clinical Science & Research and Chief Clinical Research & Development Officer at Medco Health Solutions, Inc. from December 2010 to 2012. He served as Senior Vice President of Medical Affairs Officer and Chief Medical Officer at Merck-Medco Managed Care LLC since August 1996. He led Merck-Medco Managed Care LLC's departments of clinical analysis and outcomes research, medical programs and policies, clinical practices and therapeutics, the institute for effectiveness research, health information management department and scientific affairs. He served as Senior Vice President of Medical & Analytical Affairs since 1997. He served as the President and Chief Medical officer of Medco Research Institute, L.L.C. since December 2009. He served as the Chief Medical Officer of Medco Health Solutions Inc. from 1997 to 2010. In this capacity, Dr. Epstein was responsible for formulary development, clinical guidelines, drug information services, accreditation oversight and personalized medicine services. He was responsible for analysis and reporting for Medco’s clients. From July 1995 to August 1996, he served as Merck-Medco Managed Care LLC's Vice President of Outcomes Research. He joined Merck-Medco Managed Care, LLC from Merck, where he served as an Executive Director from February 1994 to July 1995, developing clinical trials and integrating medical and drug data. He joined Merck in 1988. He was trained as an Epidemiologist and worked in public health and academia before joining the private sector. He is past President of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and served as a Director for the Drug Information Association and the International Society of Quality of Life. He served as a Director of On-Q-ity Inc. Dr. Epstein also served as a member of the boards of directors of Proteus Digital Health, Inc. a privately held healthcare technology company, from January 2013 to August 2020; the Biologics and Biosimilars Collective Intelligence Consortium, a non-profit research network, from July 2018 to July 2020 and Intellos LLC, a privately held diagnostics company, from 2016 to 2018. He was an Independent Director of Illumina Inc. since November 2012 until May 21, 2026. Dr. Epstein joined the Illumina, Inc. in November 2012. He serves on the board of Federal CDC EGAPP (Evaluation of Genomic Applications in Practice & Prevention) Stakeholder Committee and the AHRQ CERT (Centers for Education and Research on Therapeutics) Committee. He served as a Member of Advisory Board at California State Teachers Employees' Retirement System. He served as a Director of AVEO Pharmaceuticals, Inc. from December 2012 to June 2014. and served in the same position from December 31, 2012 to June 2014. He has published more than 50 peer-reviewed medical articles and book chapters and serves as a reviewer for several influential medical journals. He holds a B.S. in Biomedical Science and an M.D. from the University of Michigan and an M.S. in Preventive Medicine from the University of Maryland.

公司職務